(Morning News) The World Health Organization (WHO) included the first monoclonal antibody drugs on its pre -review list of coronary drug qualifications.
Reuters reports that the monoclonal antibody drug is called "Tocilizumab".The pre -review list of so -called coronary drug qualifications is the official drug list for developing countries for procurement benchmark.
The WHO suggested on Friday (February 11) to include the monoclonal anti -anti -resistance in the pre -qualification list, and only for patients with hospitalized crown diseases with severe diseases and severe illness.This is aimed at improving the opportunity to obtain this expensive drug in developing countries.
"Toto Monopoly" produced by Roche Switzerland is usually used to treat arthritis.Evidence shows that the tutorum monetabu can reduce the risk of death of patients with crown disease and shorten the hospitalization time of some patients with severe illnesses.
